U.S. Mortgage REITs Stock News

Kulicke and Soffa Industries stock has delivered a 180.1% return over the past year, yet the broader valuation checks currently flag the shares as expensive rather than a clear bargain. For investors, that mix of strong past gains and a weak value profile raises questions about how much optimism is already reflected in the current price. Over the last 12 months, Kulicke and Soffa Industries has returned 180.1%, which sets a high bar for any further upside that investors might expect from...

In July 2026, Alaska Air Group reported second-quarter 2026 results showing revenue rising to US$4,065 million while moving from US$172 million net income to a US$76 million net loss, with basic and diluted loss per share of US$0.68 from continuing operations. Despite higher sales and revenue over both the quarter and first half of 2026, Alaska Air Group’s swing to losses highlights the earnings pressure associated with its ongoing integration efforts, fleet initiatives, and operating cost...

Robotics and automation sit at the intersection of tight labor markets, sticky global inflation, and a growing push to lift productivity. While many regions wrestle with higher yields, shifting inflation paths, and mixed growth signals, physical AI and smart machinery offer a way for companies to do more with the staff and capital they already have. The Robotics and Automation Stocks screener focuses on businesses that aim to scale this trend efficiently rather than simply chase hype. In this...

Boston Beer earnings trigger fresh look at SAM stock Boston Beer Company (SAM) drew fresh investor attention after second quarter results showed lower revenue and earnings, yet the stock reacted constructively as management kept full year adjusted EPS guidance unchanged. The company reported second quarter revenue of US$568.34 million and net income of US$51.57 million, with management pointing to growth in SunCruiser and Angry Orchard as offsets to category pressure faced by Twisted Tea and...

Federal Realty Investment Trust has delivered a strong 42.9% return over the past year, and the current question for investors is whether that share price strength is fully backed by what the valuation work says about the stock. The stock is up 42.9% over the past year, which puts extra focus on whether the current price still leaves a margin between market value and intrinsic value. Stronger leasing activity and higher recurring cash flow can support the case that future cash generation may...

Greenbrier Companies (GBX) is in focus after fresh trading data highlighted mixed recent returns, with the stock roughly flat over the past 3 months but showing gains over the past year. See our latest analysis for Greenbrier Companies. At a share price of $49.25, Greenbrier Companies shows mixed momentum, with a 7 day share price return that declined 5.51% but a 1 year total shareholder return of 15.16%. Recent weakness contrasts with longer term gains. If Greenbrier’s recent moves have you...

In the second quarter of 2026, Highwoods Properties, Inc. reported higher sales of US$216.38 million and net income of US$94.05 million, while also affirming a quarterly dividend of US$0.50 per share payable on September 9, 2026. Together with lifting its 2026 FFO guidance and highlighting stronger leasing, improving occupancy, and a simplified development pipeline, the REIT underscored a stronger operating position built on asset sales and solid liquidity. Now we’ll examine how this...

CNB Financial (CCNE) is back on investor watch after reporting second quarter 2026 results on 23 July, followed by a KBW Summer Bank Conference appearance that keeps attention on its earnings profile and loan performance. See our latest analysis for CNB Financial. Since those July updates, CNB Financial’s share price has climbed to $35.10, with a 90 day share price return of 14.41% and a year to date share price return of 36.36%. The 1 year total shareholder return of 60.31% points to...

Oppenheimer Holdings Inc. has reported second-quarter 2026 results, with revenue rising to US$454.88 million and net income reaching US$27.35 million, while its Board declared a US$0.20 per-share quarterly dividend payable on August 28, 2026. Despite much stronger second-quarter profit than a year earlier, net income for the first half of 2026 was only US$6.77 million, highlighting how earlier-period pressures contrast with the recent quarter’s momentum in Wealth Management and Capital...

Graphic Packaging Holding stock has had a difficult run over the past few years, yet the current valuation checks suggest the market may now be pricing it on the cheap side. For investors, the gap between the share price performance and the valuation metrics is what stands out. Over the past 3 years, Graphic Packaging Holding shareholders have seen the stock decline about 50.5%, which signals a heavy reset in market expectations. The key support for the valuation is whether the company can...

Stevanato Group (STVN) stock is in focus after the company reported that liraglutide combination products using its Alina 30 and Alina 50 pen injectors received marketing authorizations in multiple European countries. See our latest analysis for Stevanato Group. The Alina approvals come as Stevanato Group’s share price shows mixed momentum, with a 30 day share price return of 8.23% and a 90 day share price return of 12.08%. However, the year to date share price return is down 3.55% and the 1...

Sempra stock has delivered a 56.5% total return over the past five years, yet its current checks suggest the shares do not stand out as a clear bargain today. Recent headlines around wildfire liability debates and major LNG project timing give investors fresh reasons to reassess what they are paying for the company’s future cash flows. A 56.5% gain over five years highlights that Sempra has already rewarded long term holders, which can limit how much potential upside remains if expectations...

Zions Bancorporation National Association (NasdaqGS:ZION) announced a 6.7% increase in its quarterly common dividend. The company also authorized a new US$75 million share repurchase program scheduled for the third quarter of 2026. Zions Bancorporation National Association focuses on regional banking services, including lending, deposit gathering, and treasury offerings for businesses and consumers. Dividend decisions and buyback authorizations are closely watched in the banking sector,...

Arcus Biosciences and Summit Therapeutics previously announced a clinical trial collaboration to test Arcus’s oral HIF-2a inhibitor casdatifan with Summit’s PD-1/VEGF bispecific antibody ivonescimab in metastatic clear cell renal cell carcinoma, adding a new combination cohort to Arcus’s ongoing ARC-20 platform study. An interesting aspect of this collaboration is that both companies retain full rights to their own drugs while sharing study costs, potentially expanding each firm’s kidney...

Recent commentary around W.W. Grainger (GWW) has focused on expectations for year over year growth in sales and earnings per share ahead of its upcoming quarterly report, giving investors fresh context for the stock. See our latest analysis for W.W. Grainger. Against this backdrop, W.W. Grainger’s share price has climbed 20.34% over the past 90 days and 37.70% year to date, while its 1 year total shareholder return of 49.53% reflects recent performance. If Grainger’s move has you thinking...

Since late July 2026, several law firms, including Kaplan Fox, Pomerantz, and Rosen Law Firm, have launched securities class action lawsuits against GPGI, Inc. over alleged misleading statements tied to its Husky Technologies Limited acquisition and subsequent earnings and guidance updates. These legal actions focus on whether investors were misinformed about the valuation and expected benefits of the Husky deal, raising fresh questions about GPGI’s disclosure practices and...

Host Hotels & Resorts has delivered a 97.7% total return over the past five years, yet valuation checks suggest the stock may still trade below an estimate of its intrinsic value. The key question is how much weight to give a Discounted Cash Flow (DCF) estimate that points to upside versus a broader set of checks that only signal a mixed value picture. A 97.7% return over five years puts Host Hotels & Resorts firmly in the group of stocks that have already rewarded patient shareholders,...

JBG SMITH Properties has seen its share price fall 43.7% over the past five years, yet current valuation work suggests the stock may now be trading below its estimated intrinsic value based on a Discounted Cash Flow (DCF) model and traditional market multiples. The share price decline of 43.7% over five years raises the question of whether sentiment has become more pessimistic than the underlying fundamentals justify. Future cash generation from JBG SMITH Properties' property portfolio can...

The bond market just sent a loud message. The Federal Reserve under Kevin Warsh kept rates on hold, yet long term Treasury yields surged to levels last seen in 2007 while shorter yields eased. At the same time, the Fed’s limited guidance has left investors guessing about inflation and future volatility. For banks and insurers with solid balance sheets, that mix of higher long term rates and shaken Fed credibility can create both openings and traps. This article walks through three financially...

Bank First stock has delivered a 137.8% return over the past 5 years, yet current valuation checks and the latest intrinsic value estimate suggest the shares may now be trading at a premium rather than offering clear value. A 137.8% share price gain over 5 years points to a stock that has already rewarded long term holders, which raises the bar for future returns from today’s price. Recent earnings growth and a higher dividend can support investors’ expectations, while any disappointment in...

AI in healthcare sits at the crossroads of powerful trends that matter for investors, from aging populations and rising treatment costs to central banks wrestling with inflation and bond yields. While higher yields and shifting policy expectations keep pressure on parts of the market, the Transformative AI Healthcare Stocks screener focuses on companies using AI to improve diagnostics, treatment decisions, hospital efficiency and remote care. These tools aim to cut waste, support clinicians...

The new 50% tariff on certain Canadian imports is shaking up cross border trade, and that can ripple through everything from farm exports to grocery shelves. Missouri and other Canada reliant states sit right in the path of this policy change, while sectors like U.S. dairy could see a different set of pressures and openings if trade barriers shift. For investors, the key question is which companies might benefit and which face higher uncertainty. This article looks at three U.S. dairy...

Thermo Fisher Scientific showcased multiple new diagnostic solutions at the 2026 Association for Diagnostics & Laboratory Medicine Annual Meeting. The EXENT Solution secured FDA 510(k) clearance for use in multiple myeloma diagnosis. The EliA CTD 13 Screen gained FDA clearance for systemic autoimmune connective tissue diseases. The company also highlighted previously cleared assays for rapid oncology and preeclampsia testing and previewed new digital tools for lab workflow efficiency. For...

Ares Management (ARES) just reported a busy second quarter, combining record fundraising and higher revenue with fresh dividend declarations for both its common and preferred stock. Investors now have new numbers and payout details to weigh. See our latest analysis for Ares Management. Ares Management’s latest earnings and dividend news landed alongside a sharp 12.73% 1 month share price return and a 7.64% 3 month share price return, yet the stock is still down 22.99% on a year to date share...